Halliburton Company (NYSE:HAL) sweetened its final offer only slightly from its first bid for rival Baker Hughes Inc., but the bump was magnified by a drop in Baker Hughes’s share price during merger talks this autumn between the world’s second- and third-largest oil-field service companies. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is 4.92%. On … Continue reading 5 Active Stocks: Halliburton Company (NYSE:HAL), Genworth Financial, Inc. (NYSE:GNW), Allergan Inc. (NYSE:AGN), Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Western Digital Corporation (NASDAQ:WDC)
Regulus Therapeutics Inc. (NASDAQ:RGLS) announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $80,000,000 of shares of its common stock, of which approximately $70,000,000 of shares are being offered by Regulus and approximately $10,000,000 of shares are being offered by an existing stockholder of Regulus, Isis Pharmaceuticals, Inc. Regulus Therapeutics Inc. (NASDAQ:RGLS) belongs to … Continue reading Stock Runners : Regulus Therapeutics Inc. (NASDAQ:RGLS), American Airlines Group Inc. (NASDAQ:AAL), H&R Block, Inc. (NYSE:HRB), Allergan Inc. (NYSE:AGN), Marine Products (NYSE:MPX)
NVIDIA Corporation (NASDAQ:NVDA) announced that its NVIDIA(R) Tegra(R) mobile processor will power the new Honda Connect in-car audio and information system in the 2015 Honda Civic, Civic Tourer and CR-V, which will be launched in Europe next year. NVIDIA Corporation (NASDAQ:NVDA) belongs to Technology sector. Its net profit margin is 12.00% and weekly performance is -3.44%. On last trading day company shares ended up $18.27. … Continue reading Trader’s Recap : NVIDIA Corporation (NASDAQ:NVDA), Merck & Co. Inc. (NYSE:MRK), Winnebago Industries, Inc. (NYSE:WGO), AT&T, Inc. (NYSE:T), Allergan Inc. (NYSE:AGN)
Shares of Hewlett-Packard Company (NYSE:HPQ) have received a consensus recommendation of “Buy” from the twenty-four ratings firms that are currently covering the company, Stock Ratings News reports. Ten equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. Hewlett-Packard Company (NYSE:HPQ) belongs to Technology sector. Its net profit margin is 4.50% and weekly performance … Continue reading Why Need to Watch : Hewlett-Packard Company (NYSE:HPQ), Staples, Inc. (NASDAQ:SPLS), BBCN Bancorp, Inc. (NASDAQ:BBCN), AGN, China Nepstar Chain Drugstore Ltd. (NYSE:NPD)
Janus Capital Group, Inc. (NYSE:JNS) announced that William H. Gross, world-renowned fixed income investor, will be joining Janus Capital Group. He will manage a recently launched Janus Global Unconstrained Bond Fund and related strategies, and will join Myron Scholes, Ph.D., and other members of the Janus team focused on global asset allocation. Janus Capital Group, Inc. (NYSE:JNS) belongs to Financial sector. Its net profit margin … Continue reading 5 Stocks Under Wall Street’s Radar : Janus Capital Group, Inc. (NYSE:JNS), Exxon Mobil Corporation (NYSE:XOM), Nike, Inc. (NYSE:NKE), CACI International Inc. (NYSE:CACI), Allergan Inc. (NYSE:AGN),
A source familiar with the matter said on Saturday, Medical-device maker Medtronic Inc and rival Covidien, are in advanced talks to combine in a deal valued at $45 billion to $50 billion. The person said, asking not to be named because the matter is not public, the deal, which would allow Medtronic to be domiciled in Ireland where Covidien is based and thus take advantage of lower tax rates, could come as soon as Monday. Minneapolis-based Medtronic, which makes cardiovascular and orthopedic devices, has a market value of about $61 billion.
An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co. Valeant said Weldon’s departure was planned, and takes effect after it completes a $1.4 billion sale of several injectable treatments to Nestle SA.
Before residents in southern Oregon overwhelmingly voted to ban genetically modified crops last month, farmers negotiated for months with a biotech company that grows engineered sugar beets near their fields. Their goal was to set up a system to peacefully coexist, an online mapping database of fields to help growers minimize cross-pollination between engineered and non-engineered crops. But the effort between farmers and Swiss company Syngenta failed, leading to the ban. Last October, Oregon Gov. John Kitzhaber directed the state’s Department of Agriculture to undertake something far more ambitious than that failed mapping effort — map GMO field locations across the entire state and establish buffer zones and exclusion areas for GE crops.